Catalyst Crew Launches Venezuelan Subsidiary LataMed AI VE for Telehealth Expansion

Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, has announced the establishment of a new Venezuelan operating subsidiary, LataMed AI VE, C.A., to support its telehealth regulatory, commercialization, and healthcare deployment initiatives within Venezuela. The subsidiary is expected to work alongside the Company’s existing framework, including Inversiones Long 33, C.A., as part of a broader regional infrastructure strategy designed to strengthen local regulatory flexibility, healthcare service operations, permit management, and long-term commercialization scalability. Management believes that establishing LataMed AI VE, C.A. may significantly enhance the Company’s ability to efficiently manage localized healthcare operations, support phased commercialization initiatives, improve operational deployment readiness, and facilitate broader telehealth platform expansion across Venezuela and other targeted Latin American markets.

LataMed AI VE, C.A. is expected to support patient onboarding systems, provider coordination capabilities, telehealth infrastructure deployment, regulatory compliance procedures, commercialization planning, healthcare analytics integration, and broader operational management as part of the Company’s evolving Latin American healthcare ecosystem. The Company continues to coordinate regulatory initiatives with applicable healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader healthcare infrastructure and commercialization objectives. Dr. Kevin Rodan Levy, Chief Executive Officer, stated: “The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution.”

Catalyst Crew continues to advance telehealth platform development, pilot deployment readiness, regulatory progression, healthcare analytics integration, and broader commercialization initiatives through its digital healthcare ecosystem, including active platform development and testing through its telehealth interface at https://latamedai.org. The Company is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets. For more information, please visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.